Marco Cerrano

1.5k total citations
43 papers, 465 citations indexed

About

Marco Cerrano is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Marco Cerrano has authored 43 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 18 papers in Genetics and 13 papers in Molecular Biology. Recurrent topics in Marco Cerrano's work include Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Marco Cerrano is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Marco Cerrano collaborates with scholars based in Italy, France and United States. Marco Cerrano's co-authors include Raphaël Itzykson, Luisa Giaccone, Benedetto Bruno, Lionel Adès, Nicolas Boissel, Emmanuel Raffoux, Hervé Dombret, Marie Sébert, Chiara Maria Dellacasa and Dario Ferrero and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Frontiers in Immunology.

In The Last Decade

Marco Cerrano

39 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Cerrano Italy	11	293	151	134	133	74	43	465
Georg‐Nikolaus Franke Germany	16	473 1.6×	120 0.8×	202 1.5×	118 0.9×	121 1.6×	69	598
Juliette Lambert France	10	305 1.0×	186 1.2×	78 0.6×	182 1.4×	93 1.3×	26	578
Bianca F. Goemans Netherlands	10	419 1.4×	200 1.3×	115 0.9×	85 0.6×	147 2.0×	34	563
Kaoru Nagata Japan	13	295 1.0×	181 1.2×	92 0.7×	80 0.6×	81 1.1×	54	490
Chun Yew Fong Australia	12	425 1.5×	266 1.8×	114 0.9×	92 0.7×	93 1.3×	50	600
Samer A. Srour United States	15	316 1.1×	136 0.9×	81 0.6×	369 2.8×	99 1.3×	98	682
Joyce Murata‐Collins United States	12	175 0.6×	136 0.9×	70 0.5×	99 0.7×	95 1.3×	31	488
Gradimir Janković Serbia	13	246 0.8×	102 0.7×	209 1.6×	73 0.5×	56 0.8×	50	437
Tsuyoshi Takahashi Japan	9	408 1.4×	91 0.6×	119 0.9×	90 0.7×	75 1.0×	22	529
AD Elias United States	10	338 1.2×	97 0.6×	111 0.8×	281 2.1×	30 0.4×	19	556

Countries citing papers authored by Marco Cerrano

Since Specialization

Citations

This map shows the geographic impact of Marco Cerrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Cerrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Cerrano more than expected).

Fields of papers citing papers by Marco Cerrano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Cerrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Cerrano. The network helps show where Marco Cerrano may publish in the future.

Co-authorship network of co-authors of Marco Cerrano

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Cerrano. A scholar is included among the top collaborators of Marco Cerrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Cerrano. Marco Cerrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dogliotti, Irene, Mario Levis, Sara Bartoncini, et al.. (2024). Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation. Cancers. 16(5). 865–865. 4 indexed citations

Lengliné, Étienne, Florence Rabian, Marco Cerrano, et al.. (2024). Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission. Blood Advances. 8(10). 2405–2409. 2 indexed citations

Ansuinelli, Michela, Maria Cristina Puzzolo, Nadia Peragine, et al.. (2024). Immunomodulatory Effect of Dasatinib Plus Blinatumomab Versus Ponatinib Plus Blinatumomab in Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Patients. Blood. 144(Supplement 1). 838–838. 1 indexed citations

D’Ardìa, Stefano, Chiara Frairia, Valentina Giai, et al.. (2023). Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience. Leukemia Research. 136. 107421–107421. 1 indexed citations

Frairia, Chiara, Emanuela Messa, Alessandro Busca, et al.. (2023). Validation of National Early Warning Score and Quick Sequential (sepsis‐related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy. European Journal Of Haematology. 110(6). 696–705. 5 indexed citations

Savelli, C., Barbara Botto, Federica Cavallo, et al.. (2023). Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions. Cancers. 16(1). 46–46. 6 indexed citations

Freilone, Roberto, Benedetto Bruno, Ernesta Audisio, et al.. (2023). Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges. Current Treatment Options in Oncology. 24(6). 693–710. 7 indexed citations

Aydin, Semra, Roberto Passera, Marco Cerrano, et al.. (2023). Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center Analysis. Cancers. 15(4). 1002–1002. 7 indexed citations

Arrigo, Giulia, Stefano D’Ardìa, Chiara Frairia, et al.. (2023). Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors. Cancers. 15(13). 3512–3512. 16 indexed citations

10.

Frairia, Chiara, Alessandro Busca, Silvia Corcione, et al.. (2023). Levofloxacin prophylaxis omission in acute myeloid leukemia during post induction aplasia: a single center study. Mediterranean Journal of Hematology and Infectious Diseases. 15(1). e2023022–e2023022. 5 indexed citations

11.

Cerrano, Marco, Sylvie Chevret, Emmanuel Raffoux, et al.. (2023). Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis. Annals of Hematology. 102(4). 761–768. 6 indexed citations

12.

Käyser, Sabine, Chiara Sartor, Fabio Giglio, et al.. (2023). Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease. Haematologica. 109(5). 1385–1392. 3 indexed citations

13.

Cerrano, Marco, Daniela Di Cuonzo, Stefano D’Ardìa, et al.. (2022). Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study. Annals of Hematology. 101(4). 855–867. 29 indexed citations

14.

Arrigo, Giulia, Stefano D’Ardìa, Ernesta Audisio, et al.. (2022). Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature. Acta Haematologica. 145(5). 566–570. 5 indexed citations

15.

Cerrano, Marco, Lucia Brunello, Chiara Maria Dellacasa, et al.. (2021). Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience. Annals of Hematology. 100(7). 1837–1847. 15 indexed citations

16.

Giaccone, Luisa, Francesco Felicetti, Marco Cerrano, et al.. (2020). Optimal Delivery of Follow-Up Care After Allogeneic Hematopoietic Stem-Cell Transplant: Improving Patient Outcomes with a Multidisciplinary Approach. Journal of Blood Medicine. Volume 11. 141–162. 16 indexed citations

17.

Cerrano, Marco, Marco Ruella, Miguel‐Angel Perales, et al.. (2020). The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice. Frontiers in Immunology. 11. 888–888. 49 indexed citations

18.

Lia, Giuseppe, Clara Di Vito, Marco Cerrano, et al.. (2020). Extracellular Vesicles After Allogeneic Hematopoietic Cell Transplantation: Emerging Role in Post-Transplant Complications. Frontiers in Immunology. 11. 422–422. 17 indexed citations

19.

Cerrano, Marco & Raphaël Itzykson. (2019). New Treatment Options for Acute Myeloid Leukemia in 2019. Current Oncology Reports. 21(2). 16–16. 32 indexed citations

20.

Fava, Carmen, Irene Dogliotti, Paola Berchialla, et al.. (2015). IMATINIB DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS ON PATIENTS IN CLINICAL PRACTICE. Haematologica. 100. 232–232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact